PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 112 (2) , 89-104
Abstract
Insulin resistance in peripheral tissues is the primary cause responsible for onset of type II diabetes mellitus. Recently, the genetic and biochemical dissection of intracellular signalling pathways transducing the metabolic and mitogenic effects of insulin has contributed to the understanding of the molecular causes of this insulin resistance. In particular, important efforts have been developed to comprehend the role of negative regulators of insulin signalling, since they might represent future therapeutical targets to reduce insulin resistance in peripheral tissues. Herein, we will briefly review major intracellular signalling pathways activated by insulin and how they are negatively regulated by distinct mechanisms. In particular, the role of PTEN and SHIP2, two phosphoinositide phosphatases recently implicated as negative modulators of insulin signalling, is in focus. Current knowledge on the role of PTEN and SHIP2 in insulin resistance, type II diabetes and related disorders will also be discussed.Keywords
This publication has 163 references indexed in Scilit:
- Steatosis: Co-factor in Other Liver Diseases *Hepatology, 2005
- Grb10 and Grb14: enigmatic regulators of insulin action – and more?Biochemical Journal, 2005
- Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic SyndromeHepatology, 2003
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Global and societal implications of the diabetes epidemicNature, 2001
- The SH2 Domain Containing Inositol 5-Phosphatase SHIP2 Controls Phosphatidylinositol 3,4,5-Trisphosphate Levels in CHO-IR Cells Stimulated by InsulinBiochemical and Biophysical Research Communications, 2001
- Molecular Cloning of Rat SH2-Containing Inositol Phosphatase 2 (SHIP2) and Its Role in the Regulation of Insulin SignalingBiochemical and Biophysical Research Communications, 1999
- High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in miceCurrent Biology, 1998
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- In vivo andin vitro studies of vanadate in human and rodent diabetes mellitusMolecular and Cellular Biochemistry, 1995